A chronic high glucose treatment decreases proteasome activities and increases apoptosis in human islets. by Christophe Broca (538652)

Inner medullary expression of the V2 vasopressin receptor. by Sophie Constantin Lütken (689916)

Subjects:

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…Immortalized HBECs with (A) lenti-<i>KRas</i>^V12, (B) lenti-<i>KRas</i>^V12 and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i>^V12, sh<i>p53</i>, and <i>myc</i> overexpression. …”

MYCN overexpression leads to decreased <i>id2a</i> expression in early SCG. by Rodrigo Ibarra-García-Padilla (19697623)

XRP44X decreases tumour burden in a prostate cancer bone metastasis model. by Kostyantyn Semenchenko (112316)

Lovastatin improves microvascular function and decreases leukocyte rolling and adhesion during PbA infection. by Patricia A. Reis (109310)

PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues. by Hiromi Hyodo (484509)

“…One unit means a decrease in OD₆₂₀ per second. …”

Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

Pharmacological treatments decrease actin polymerization. by Romain Ferru-Clément (701878)

Chronic DCF treatment decreases ATP content (a) and the energy charge (b) of striatal slices by Elisaveta Milusheva (45672)

DOX decreases body mass gain over time in a sub-chronic toxicity model. by Gonçalo C. Pereira (156673)

Pre-treatment of striatal slices by DCF decreases HDA uptake (a) and dopamine content (b) by Elisaveta Milusheva (45672)

Mutation (_mut) in the extracellular loop (ECL) 2 leads to decreased <i>cis</i>- and <i>trans</i>-interaction of claudins (Cldns). by Nora Gehne (4357123)

Overexpression of wild-type and mutant ALDH3A1 retards hTCEpi cell proliferation. by Vindhya Koppaka (845151)

“…After 4 d, cells were trypsinized and viable cells were counted using trypan blue exclusion on a hemocytometer. Consecutively, 2.0 x 10⁵ cells were transferred to a new dish and this process repeated for a total of 8 passages, i.e., for 32 d until treated cells showed decreasing cell numbers. …”

AR1’s occurrence gives rise to a decreased preference of ABP for AR2 and 3. by Li-Dong Huang (5659273)

BrDU labeling of corneal epithelial cells. by Vindhya Koppaka (845151)

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

TIG3 decreases cell survival. by Tiffany M. Scharadin (345930)

“…<b>A</b> TIG3 expression decreases cell number. Values are mean ± SEM, n = 3. …”

Sphingomyelinase activity decreases in Alzheimer’s disease. by Alfred N. Fonteh (486638)